Blog
Blog
Health Care and Life Science at HBS
Health Care and Life Science at HBS
Globally, there are about 350 million people, or 8% of the population, with a rare disease, yet only 5% of these diseases have an approved therapy. It’s a dilemma that is historically overlooked, largely because it’s hard to make a profit from a treatment that affects so few people. How do we empower patients with rare diseases when a lack of treatment options and awareness can result in significant health complications? [...]
As an HBS student in Professor Vicki Sato’s Commercializing Science class, I wanted to tackle an unmet global health care need by applying my engineering and business skills to a solvable problem. Working with my co-founders, we saw an opportunity to supply much-needed vaccines worldwide without refrigeration or cold storage using silk. [...]
As the associate director of the Health Care Initiative focusing on life sciences, I’ve managed the Blavatnik Fellowship since 2013 and have had the privilege of seeing extraordinary innovators work on some of the world’s toughest health care challenges. [...]
Over the years, women working in healthcare have been asked why “women’s health” solutions are not just “health solutions.” We’ve been asked if we really need to build separate care paths for women. We’ve been told the market for women’s health is too “niche.” [...]
Out of the many benefits of pursuing an MBA from Harvard Business School, the alumni network is arguably one of the greatest. With more than 80,000 alumni working in leadership positions globally, there is no shortage of excellence to tap into. At the same time, that number can be overwhelming when it comes to finding the right people to build out your professional network. Fortunately, the HBS community has found a way to make that task less daunting and more valuable for alumni, faculty and students alike. [...]
Load More Loading...